Navigation Links
Seven More Plaintiffs Sue Stryker over Defective Hip Implant Devices
Date:9/11/2012

WEST PALM BEACH, Fla., Sept. 11, 2012 /PRNewswire/ -- South Florida law firm Searcy Denney Scarola Barnhart & Shipley PA (Searcy Denney) today announced that it has filed seven additional lawsuits against Howmedica Osteonics Corporation, dba Stryker Orthopaedics, over the company's Rejuvenate and ABG II hip implant systems.  

Searcy Denney filed the nation's first lawsuit over the recalled medical device in early August on behalf of a plaintiff in Boca Raton, Fla. The expanded claims against Stryker include allegations from plaintiffs in Lake Worth, Fla., Boynton Beach, Fla., Pillage, Minn., Boca Raton, Fla., St. Cloud, Minn., and two from Tucson, Ariz. All of the suits were filed in Bergen County (N.J.) Superior Court and allege that Stryker negligently developed, tested, manufactured, distributed, marketed, and sold its defective "Rejuvenate System."

"We have reached a decisive stage in this litigation as legitimate claims are now proliferating nationwide," said Cal Warriner, a shareholder at Searcy Denney who represents the eight total plaintiffs. "The Rejuvenate System has only been on the market since 2009, yet, just a few years later, an overwhelming number of patients have suffered heavy metal toxicity."

"Stryker marketed its devices as an improvement over and alternative to other metal-on-metal hip implants when in fact these systems have caused significantly more severe injuries than comparable systems on the market."

In April 2012, Stryker issued an Urgent Field Safety Notice to surgeons and hospitals, which acknowledged reports of heavy metal contamination, such as that experienced by the eight total plaintiffs. Stryker then issued a recall of the devices in Canada, followed in July by a U.S. voluntary recall of the same Rejuvenate and ABG II hip replacement systems.

"The recall is a clear admission by Stryker that its product is defective and dangerous," said Warriner.

The seven new plaintiffs were implanted with the devices between June 2009 and September 2011 and underwent corrective revision surgery in as little as eight months. In each instance, the revision surgery revealed heavy metal toxicity, including "the presence of milky, turbid fluid; large pseudotumor formation; soft tissue necrosis; muscle loss and/or bony necrosis at the proximal femur," according to the complaint.

Stryker's Rejuvenate System, which features a chrome cobalt neck and titanium stem, is marketed to patients in need of primary total hip arthroplasty or replacement, often due to painful joint diseases caused by non-inflammatory degenerative arthritis.

Thousands of Stryker victims have been notified that their recalled hip may be poisoning them and Stryker has given no assurance that it will pay to have the device removed. "I get several calls a day from distraught clients wondering if this disaster is going to bankrupt them," said Warriner. "Many simply can't afford to have it removed. Stryker has really aggravated a lot of doctors with its response to this recall. Doctors are jumping ship to other manufacturers' products because they are disgusted."

The plaintiffs seek compensatory, consortium, actual, and punitive damages. They are requesting a jury trial.

About Searcy Denney Scarola Barnhart & Shipley, PA

A nationally recognized trial law firm, Searcy Denney Scarola Barnhart & Shipley, P.A. is committed to protecting victims of negligence, defective products and corporate wrongdoing.  Over the past 35 years, the firm has represented clients in courtrooms throughout Florida and across the nation.


'/>"/>
SOURCE Searcy Denney Scarola Barnhart & Shipley PA
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Wave of Celebrity Support Boosts Global Effort to Eliminate Seven Diseases by 2020
2. Seventeenth Patient Dosed in Neuralstem ALS Stem Cell Trial
3. 3-V Biosciences To Present at the Seventh Annual JMP Securities Healthcare Conference
4. Arena Pharmaceuticals to Present at the Seventh Annual JMP Securities Healthcare Conference
5. Pricing and Reimbursement in Russia - Big Pharma Take Advantage of Reimbursement for Costly Drugs Through the DLOs Seven Nosologies Program
6. Seventeen Banner Health facilities achieve final stage of electronic medical record adoption
7. RD Legal Funding Provides Immediate Settlement Financing to Growing Number of Yaz and Yasmin Plaintiffs
8. Problems With the Stryker Rejuvenate Hip System
9. The Gomez Law Firm Launches New Website Representing Victims Of Defective Stryker Hip Replacement Systems
10. Stryker Initiates Voluntary Product Recall of Modular-Neck Stems
11. Terso Solutions partners with Champion Medical Technologies to offer fully automated tracking of Tissue and Implantable Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... -- Center Point Clinical Services, creator of ... today study results presented in two separate posters at ... and Specialty Pharmacy annual meeting in ... demonstrated that pharmacist-led patient interventions during clinical studies enhance ... crucial to generating the robust and high quality study ...
(Date:3/28/2017)... France and TEL AVIV, Israel , ... a subsidiary in Israel . This new business ... will be mostly dedicated to research and development of novel assays ... Ltd will also, when relevant, locally support commercialization and sales development ... ...
(Date:3/28/2017)... FRANCISCO , March 28, 2017 ...  is expected to reach a value of USD 4.5 ... Grand View Research, Inc. Proper closure of injured tissues ... structure and function. Postoperative leakages occur in 3% to ... complication. They are responsible for one third of postoperative ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... March 28, 2017 , ... Medforce Technologies, Inc., ... to announce it has joined the National Association for Home Care and Hospice ... ill, disabled, and dying Americans of all ages and the caregiver who provide ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... announces today that the University of Pittsburgh Medical Center (UPMC) will acquire QuikClot® ... Western Pennsylvania. , The program, developed in association with efforts by the American ...
(Date:3/28/2017)... ... March 28, 2017 , ... Calibration, qualification, and the ... results and maintaining GMP and USP compliance. In a new webinar from METTLER ... requirements " these requirements are explained. The challenge is to determine how ...
(Date:3/28/2017)... Francisco, CA (PRWEB) , ... March 28, 2017 , ... ... people suffering from acne, access to quality care can be limited while the desire ... company that offers customized prescription acne care for every customer online, today released its ...
(Date:3/28/2017)... Ohio (PRWEB) , ... March 28, 2017 , ... Columbus ... was selected as one of few medical professionals in the country to sit on ... Founder of Juvly Aesthetics, in just 2 years Dr. Harper helped propel the clinic ...
Breaking Medicine News(10 mins):